Potential and limitations of PKA/ PKG inhibitors for platelet studies
Cyclic nucleotides (cAMP and cGMP) and corresponding protein kinases, protein kinase A (PKA) and protein kinase G (PKG), are the main intracellular mediators of endothelium-derived platelet inhibitors. Pharmacological PKA/PKG inhibitors are often used to discriminate between these two kinase activit...
Main Authors: | Valentina Shpakova, Natalia Rukoyatkina, Ulrich Walter, Stepan Gambaryan |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-08-01
|
Series: | Platelets |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09537104.2021.2003316 |
Similar Items
-
The Role of NO/sGC/cGMP/PKG Signaling Pathway in Regulation of Platelet Function
by: Stepan Gambaryan
Published: (2022-11-01) -
Editorial: Cyclic nucleotide phosphodiesterases (PDEs) signaling in the endocrine system
by: Federica Campolo, et al.
Published: (2025-01-01) -
Aβ oligomers from human brain impair mossy fiber LTP in CA3 of hippocampus, but activating cAMP-PKA and cGMP-PKG prevents this
by: Shan-Xue Jin, et al.
Published: (2022-10-01) -
EDNRB inhibits the growth and migration of prostate cancer cells by activating the cGMP-PKG pathway
by: Li Xun, et al.
Published: (2024-01-01) -
GATA1-mediated macrophage polarization via TrkB/cGMP–PKG signaling pathway to promote the development of preeclampsia
by: Wushan Li, et al.
Published: (2025-01-01)